Format

Send to

Choose Destination
Endocrine. 2014 Feb;45(1):15-25. doi: 10.1007/s12020-013-9992-0. Epub 2013 Jul 3.

Sarcopenic obesity in aging population: current status and future directions for research.

Author information

1
Department of Geriatric Medicine, Ehime University Graduate School of Medicine, Shitsukawa, Toon, Ehime, 791-0295, Japan, koharak@m.ehime-u.ac.jp.

Abstract

The combination of sarcopenia and obesity, an age-related change in body composition, is a concern in the aged society. Sarcopenic obesity is not the combination of two conditions, but is more related to cardio-metabolic and functional abnormalities. Sarcopenic obesity is associated with more physical functional decline than simple obesity. Sarcopenic obesity may be more insulin resistant, and have a higher risk for metabolic syndrome and atherosclerosis than simple obesity. However, the prevalence of sarcopenic obesity differs substantially among studies because of the lack of a standard definition. For further understanding of the pathophysiological role of sarcopenic obesity, a standardized definition for both sarcopenia and obesity is necessary.

PMID:
23821364
DOI:
10.1007/s12020-013-9992-0
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center